Navigation Links
ShangPharma Announces Second Quarter 2011 Results
Date:8/22/2011

SHANGHAI, Aug. 22, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the quarter ended June 30, 2011.

To help management and investors gain a better understanding of ShangPharma's operating performance, the Company presents certain non-GAAP measures, each of which excludes expenses relating to or the effect of share-based compensation. See "About Non-GAAP Financial Measures" and "Reconciliation of GAAP to Non-GAAP Financial Data" below for more information about the non-GAAP financial measures included in this press release.

Second Quarter 2011 Highlights

  • Net revenues increased by 26.0% year-over-year to $27.5 million.
  • Net revenues from China-based customers increased 202.7% year-over-year to $2.7 million.  
  • GAAP gross profit increased by 23.6% year-over-year to $9.1 million. GAAP gross margin was 33.3%, compared with 33.9% in the second quarter of 2010.
  • Non-GAAP gross profit increased by 26.7% year-over-year to $9.5 million. Non-GAAP gross margin was 34.7% compared with 34.5% in the second quarter of 2010.
  • GAAP profit from operations decreased by 12.7% year-over-year to $2.8 million. GAAP operating margin was 10.3%, compared with 14.8% in the second quarter of 2010.
  • Non-GAAP profit from operations increased by 22.2% year-over-year to $4.2 million. Non-GAAP operating margin was 15.2% compared with 15.7% in the second quarter of 2010.
  • GAAP net income decreased by 19.0% year-over-year to $3.4 million. GAAP diluted earnings per ADS were $0.18, compared with $0.26 in the second quarter of 2010.
  • Non-GAAP net income increased by 9.0% year-over-year to $4.7 million.  Non-GAAP dil
    '/>"/>

  • SOURCE ShangPharma Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related biology technology :

    1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
    2. ShangPharma Announces First Quarter 2011 Results
    3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
    4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
    5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
    6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
    7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
    8. Neurologix Announces Second Quarter 2011 Financial Results
    9. Bion Announces New U.S. Patent for Phosphorus Removal
    10. ViaCyte Announces Executive Management Changes
    11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/14/2014)... a leading provider of strategic communications services to corporations and organizations ... the United States and Europe ... is returning to the firm,s Washington, D.C. ... than two years of service as Associate Commissioner for the Office ...
    (Date:1/14/2014)... and BETHESDA, Md. , Jan. ... together with two institutes from the National Institutes of ... for bringing safer, more effective treatments to patients on ... Center for Advancing Translational Sciences (NCATS) and the National ...
    (Date:1/14/2014)... MD (PRWEB) January 14, 2014 ... to developing innovative information technology solutions for patients, ... health care stakeholders, announced today the signing of ... US Food and Drug Administration (FDA). This ...
    (Date:1/14/2014)... Rochester, NY (PRWEB) January 14, 2014 During ... is now known as “The Doctor’s Plague.” In this time ... their hands. This led, at times, to the death of ... staff today don’t know that they may be unwittingly transmitting ...
    Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
    ... 29 Cardiogenesis Corporation (Pink Sheets: CGCP), announced that ... ended March 31, 2009 prior to market open on ... that President Richard P. Lanigan and Senior Vice President ... an investor conference call that day at 12:00 p.m. ...
    ... CITY, April 29 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX: AEZ; ... on endocrine therapy and oncology, today announced it has received ... regained compliance with Listing Rule 5450 (a) (1) relating to ... this rule, the Company was required to evidence a closing ...
    ... - Results to be Presented at World ... AB announced today that it has completed its open Phase ... nephropathy, a,glomerulonephritis leading to end-stage renal disease. Nefecon is an ... in the kidneys through suppression of the gut immune,system. , ...
    Cached Biology Technology:Cardiogenesis Corporation to Report First Quarter 2009 Results on May 14th 2Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R) 2Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R) 3
    (Date:4/17/2014)... recent Yokahama IPCC meeting painted a stark warning on ... which has a greenhouse effect 32 times that of ... shown that humic substances act as fully regenerable electron ... are held in wetlands instead of being released to ... system is disrupted it may enter into a vicious ...
    (Date:4/17/2014)... is the process whereby the genetic information of ... as proteins, which have numerous different functions in ... important intermediary during gene expression, by relating the ... involved in manufacturing proteins. , By examining ... present in an organism at a given time, ...
    (Date:4/17/2014)... uncovered a new way the immune system may fight ... to use immune cells to treat illness. , The ... immunological equivalent of "neighborhood police" specialized squads of ... instead of an entire city, the body. , Scientists ... have shown that the liver, skin and uterus each ...
    Breaking Biology News(10 mins):Methane climate change risk suggested by proof of redox cycling of humic substances 2Rapid and accurate mRNA detection in plant tissues 2Some immune cells defend only 1 organ 2
    ... is available in German . , Leipzig. ... of having a much greater effect on global air ... drawn by researchers after examining a dust cloud that ... to extremely high concentrations of particulate matter in Central ...
    ... remote Siberian village will discuss their artworks, which are ... of Science (AAAS) Gallery, 1200 New York Ave, NW, ... years old, will describe their works and answer questions ... p.m. 14 May in the AAAS auditorium. The works, ...
    ... insidious screw worm fly in Yemen, is threatening livelihoods, in ... life. In recent weeks, a Ministerial delegation was at the ... for emergency assistance to fight the deadly pest. The ... wound of a warm-blooded animal. The maggots then feast off ...
    Cached Biology News:Arable land can have a negative impact on air quality 2Arable land can have a negative impact on air quality 3Arable land can have a negative impact on air quality 4Arable land can have a negative impact on air quality 5May 14 AAAS Lecture and videoteleconference on artworks by Siberian schoolchildren 2Screw worm outbreak in Yemen 2Screw worm outbreak in Yemen 3
    Purified anti-PI3K p110 delta...
    Biotin anti-mouse Ly-49C/F/I/H...
    ... Antigen Afinity Purified Tyrosine Hydroxylase ... antibody was raised against synthetic ... residues surrounding the phospho-Ser40 of ... antibody was purified by sequential ...
    Mouse Wnt-9b Biotinylated Affinity Purified PAb ENTREZ GeneID: 22412...
    Biology Products: